Trial intelligence / Profile preview

Topical Amlodipine in Raynaud's Phenomenon

2009-018194-31Phase 2Unknown

Sponsor
Pharmarama
Start
Mar 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of amlodipine in Raynaud disease, sponsored by Pharmarama. Primary endpoints: Improvement of digital blood flow and symptoms and Practicality of gel application. Status: unknown.

02

Drugs

amlodipine
03

Conditions

Raynaud disease

Beyond the preview

Go deeper on 2009-018194-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-018194-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call